Docetaxel has been approved by the UK National Institute for Health and Clinical Excellence (NICE), Media release 02 February 2013 Pages: 2 - 2
Rituximab gives standard RA therapies a run for their money Meeting report 02 February 2013 Pages: 3 - 4
The rate at which Aboriginal injecting drug users with HIV infections initiate antiretroviral therapy (ART) is slower than that of non-Aboriginal patients, Clinical study 02 February 2013 Pages: 6 - 6
Risperidone may be the most cost-effective atypical antipsychotic for the treatment of acute manic episodes in bipolar I disorder, Clinical study 02 February 2013 Pages: 7 - 7
In Finland, repaglinide is dominant to nateglinide as combination therapy with metformin for the treatment of type 2 diabetes mellitus inadequately controlled with monotherapy, Clinical study 02 February 2013 Pages: 8 - 8
Once-daily nitrates more benefit in diabetes, hypercholesterolaemia Clinical study 02 February 2013 Pages: 9 - 9
Number of prescriptions, not inappropriate drugs, predicts QOL Clinical study 02 February 2013 Pages: 9 - 9
Canada's health policies on price controls of drugs are leading to shortages of supplies, News item 02 February 2013 Pages: 10 - 10
New legislation in Spain will lead to losses for the pharmaceutical industry, says the president of the Spanish drug industry association Farmindustria, Humberto Arnes, News item 02 February 2013 Pages: 10 - 10
Inadequate communication on the reimbursement system in Latvia is leading to unexpected charges for patients, News item 02 February 2013 Pages: 11 - 11
Pharmaceutical Research Companies in the US made contributions totalling more than $US8 billion in cash and products to philanthropic causes in 2005, Media release 02 February 2013 Pages: 11 - 11